Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.065 | 0.2 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.3 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |